MME and neoplasm: (6) concluded that the immunophenotype CD10 expression rate and CK7 and EMA expression rate of OPRCC are higher, and the immunophenotype is more similar to type II PRCC, confirming that OPRCC is an immunophenotype tumor group that is more similar to type II PRCC.